Markus Blaess

572 total citations
25 papers, 452 citations indexed

About

Markus Blaess is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Markus Blaess has authored 25 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Hematology. Recurrent topics in Markus Blaess's work include Sphingolipid Metabolism and Signaling (10 papers), Lipid Membrane Structure and Behavior (4 papers) and Dermatology and Skin Diseases (3 papers). Markus Blaess is often cited by papers focused on Sphingolipid Metabolism and Signaling (10 papers), Lipid Membrane Structure and Behavior (4 papers) and Dermatology and Skin Diseases (3 papers). Markus Blaess collaborates with scholars based in Germany, United States and Belgium. Markus Blaess's co-authors include Hans‐Peter Deigner, Ralf A. Claus, Gabriel A. Bonaterra, Ralf Kinscherf, René Csük, Lars Kaiser, Michael Bauer, Jürgen Metz, Martin Sauer and Michael Cantz and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

Markus Blaess

25 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Blaess Germany 12 242 76 71 63 42 25 452
Fei Xiong China 15 340 1.4× 148 1.9× 97 1.4× 80 1.3× 31 0.7× 39 766
Weiwei Yuan China 16 383 1.6× 111 1.5× 51 0.7× 50 0.8× 26 0.6× 41 708
Wan Hee Yoo South Korea 13 166 0.7× 134 1.8× 51 0.7× 150 2.4× 15 0.4× 22 558
Wesam Bassiouni Canada 7 150 0.6× 41 0.5× 45 0.6× 33 0.5× 39 0.9× 19 403
Xinxin Liu China 13 207 0.9× 197 2.6× 37 0.5× 39 0.6× 21 0.5× 36 520
Sara C. Sebag United States 12 169 0.7× 75 1.0× 40 0.6× 111 1.8× 26 0.6× 15 453
Yitao Ou China 13 300 1.2× 121 1.6× 71 1.0× 145 2.3× 16 0.4× 19 603
Xinming Xie China 16 395 1.6× 127 1.7× 74 1.0× 64 1.0× 59 1.4× 53 758
Lei‐Yun Wang China 12 206 0.9× 75 1.0× 43 0.6× 39 0.6× 16 0.4× 30 501
Jae-Ryong Kim South Korea 9 195 0.8× 153 2.0× 32 0.5× 47 0.7× 18 0.4× 11 458

Countries citing papers authored by Markus Blaess

Since Specialization
Citations

This map shows the geographic impact of Markus Blaess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Blaess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Blaess more than expected).

Fields of papers citing papers by Markus Blaess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Blaess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Blaess. The network helps show where Markus Blaess may publish in the future.

Co-authorship network of co-authors of Markus Blaess

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Blaess. A scholar is included among the top collaborators of Markus Blaess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Blaess. Markus Blaess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blaess, Markus, et al.. (2024). Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs. International Journal of Molecular Sciences. 25(17). 9344–9344. 2 indexed citations
2.
Grünewald, Benedikt, Jonathan Wickel, Nina Hahn, et al.. (2024). Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy. Molecular Therapy. 32(7). 2113–2129. 11 indexed citations
3.
Blaess, Markus, et al.. (2022). Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19. SHILAP Revista de lepidopterología. 484–509. 1 indexed citations
4.
Blaess, Markus, et al.. (2021). Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. International Journal of Molecular Sciences. 22(4). 1797–1797. 13 indexed citations
5.
6.
Kaiser, Lars, Markus Blaess, René Csük, et al.. (2020). Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic Pathways. International Journal of Molecular Sciences. 21(17). 6092–6092. 2 indexed citations
7.
Blaess, Markus, Lars Kaiser, Martin Sauer, René Csük, & Hans‐Peter Deigner. (2020). COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. International Journal of Molecular Sciences. 21(14). 4953–4953. 42 indexed citations
8.
9.
Blaess, Markus & Hans‐Peter Deigner. (2019). Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy. International Journal of Molecular Sciences. 20(16). 3967–3967. 25 indexed citations
10.
Blaess, Markus, Ralf A. Claus, Matthias Kohl, et al.. (2017). NB 06: From a simple lysosomotropic aSMase inhibitor to tools for elucidating the role of lysosomes in signaling apoptosis and LPS-induced inflammation. European Journal of Medicinal Chemistry. 153. 73–104. 16 indexed citations
11.
Saraiva, J., Tilman E. Klassert, Markus Blaess, et al.. (2017). Combination of Classifiers Identifies Fungal-Specific Activation of Lysosome Genes in Human Monocytes. Frontiers in Microbiology. 8. 2366–2366. 4 indexed citations
12.
Saraiva, J., Marcus Oswald, Tilman E. Klassert, et al.. (2017). Fungal biomarker discovery by integration of classifiers. BMC Genomics. 18(1). 601–601. 3 indexed citations
13.
Rinke, Jenny, Jörg P. Müller, Markus Blaess, et al.. (2017). Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms. Leukemia. 31(9). 1936–1943. 23 indexed citations
14.
Blaess, Markus, Ralf A. Claus, Hortense Slevogt, et al.. (2016). Differential Biphasic Transcriptional Host Response Associated with Coevolution of Hemagglutinin Quasispecies of Influenza A Virus. Frontiers in Microbiology. 7. 1167–1167. 11 indexed citations
15.
Rittirsch, Daniel, Sandro Lindig, Kai Sprengel, et al.. (2016). An Integrated Clinico-transcriptomic Approach Identifies a Central Role of the Heme Degradation Pathway for Septic Complications after Trauma. Annals of Surgery. 264(6). 1125–1134. 17 indexed citations
16.
Blaess, Markus, et al.. (2015). Stereospecific induction of apoptosis in tumor cells via endogenous C16-ceramide and distinct transcripts. Cell Death Discovery. 1(1). 15013–15013. 11 indexed citations
17.
Blaess, Markus, Ralf A. Claus, & Hans‐Peter Deigner. (2015). HPLC separation and ultrasensitive optical quantification of ceramide species applying 7-(diethylamino)coumarin-3-carbonyl azide derivatisation. Journal of Chromatography B. 986-987. 123–128. 7 indexed citations
18.
Gonnert, Falk A., Clemens L. Bockmeyer, Markus Blaess, et al.. (2012). Hyperresponsiveness of mice deficient in plasma-secreted sphingomyelinase reveals its pivotal role in early phase of host response. Journal of Lipid Research. 54(2). 410–424. 12 indexed citations
19.
Claus, Ralf A., et al.. (2001). Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. The FASEB Journal. 15(3). 807–814. 62 indexed citations
20.
Deigner, Hans‐Peter, Ralf A. Claus, Gabriel A. Bonaterra, et al.. (2001). Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. The FASEB Journal. 15(3). 807–814. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fei Xiong Breakdown of academic impact, for papers by Weiwei Yuan Breakdown of academic impact, for papers by Wan Hee Yoo Breakdown of academic impact, for papers by Wesam Bassiouni Breakdown of academic impact, for papers by Xinxin Liu Breakdown of academic impact, for papers by Sara C. Sebag Breakdown of academic impact, for papers by Yitao Ou Breakdown of academic impact, for papers by Xinming Xie Breakdown of academic impact, for papers by Lei‐Yun Wang Breakdown of academic impact, for papers by Jae-Ryong Kim
Rankless by CCL
2026